Annual Net Income
-$18.35 M
+$1.34 M+6.79%
31 December 2023
Summary:
Theriva Biologics annual net profit is currently -$18.35 million, with the most recent change of +$1.34 million (+6.79%) on 31 December 2023. During the last 3 years, it has fallen by -$8.31 million (-82.70%). TOVX annual net income is now -1253.37% below its all-time high of -$1.36 million, reached on 01 December 2005.TOVX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$7.73 M
+$590.00 K+7.09%
01 September 2024
Summary:
Theriva Biologics quarterly net profit is currently -$7.73 million, with the most recent change of +$590.00 thousand (+7.09%) on 01 September 2024. Over the past year, it has dropped by -$4.42 million (-133.91%). TOVX quarterly net income is now -371.09% below its all-time high of $2.85 million, reached on 01 December 2017.TOVX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$26.69 M
-$4.42 M-19.86%
01 September 2024
Summary:
Theriva Biologics TTM net profit is currently -$26.69 million, with the most recent change of -$4.42 million (-19.86%) on 01 September 2024. Over the past year, it has dropped by -$7.38 million (-38.23%). TOVX TTM net income is now -5238.40% below its all-time high of -$500.00 thousand, reached on 01 March 1993.TOVX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.8% | -133.9% | -38.2% |
| 3 y3 years | -82.7% | -46.8% | -87.1% |
| 5 y5 years | -19.9% | -146.1% | -74.4% |
TOVX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -82.7% | +6.8% | -133.9% | +7.1% | -87.1% | at low |
| 5 y | 5 years | -82.7% | +6.8% | -267.4% | +7.1% | -177.6% | at low |
| alltime | all time | -1253.4% | +58.0% | -371.1% | +43.3% | -5238.4% | +39.0% |
Theriva Biologics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.73 M(-7.1%) | -$26.69 M(+19.9%) |
| June 2024 | - | -$8.32 M(+61.0%) | -$22.27 M(+17.0%) |
| Mar 2024 | - | -$5.17 M(-5.8%) | -$19.04 M(+3.7%) |
| Dec 2023 | -$18.35 M(-6.8%) | -$5.49 M(+66.1%) | -$18.35 M(-5.0%) |
| Sept 2023 | - | -$3.30 M(-35.0%) | -$19.31 M(-5.8%) |
| June 2023 | - | -$5.08 M(+13.5%) | -$20.50 M(+3.1%) |
| Mar 2023 | - | -$4.48 M(-30.5%) | -$19.89 M(+1.0%) |
| Dec 2022 | -$19.68 M(+38.0%) | -$6.45 M(+43.5%) | -$19.68 M(+6.4%) |
| Sept 2022 | - | -$4.49 M(+0.3%) | -$18.50 M(+7.0%) |
| June 2022 | - | -$4.48 M(+4.8%) | -$17.29 M(+8.0%) |
| Mar 2022 | - | -$4.27 M(-18.8%) | -$16.00 M(+12.2%) |
| Dec 2021 | -$14.27 M(+42.1%) | - | - |
| Dec 2021 | - | -$5.26 M(+60.8%) | -$14.27 M(+28.4%) |
| Sept 2021 | - | -$3.27 M(+2.4%) | -$11.11 M(+11.8%) |
| June 2021 | - | -$3.19 M(+26.0%) | -$9.94 M(+3.4%) |
| Mar 2021 | - | -$2.54 M(+20.2%) | -$9.62 M(-4.3%) |
| Dec 2020 | -$10.04 M(-34.4%) | -$2.11 M(+0.3%) | -$10.04 M(-9.3%) |
| Sept 2020 | - | -$2.10 M(-26.6%) | -$11.07 M(-21.4%) |
| June 2020 | - | -$2.87 M(-3.3%) | -$14.09 M(-4.5%) |
| Mar 2020 | - | -$2.96 M(-5.6%) | -$14.76 M(-3.6%) |
| Dec 2019 | -$15.30 M(+14.5%) | -$3.14 M(-38.7%) | -$15.30 M(-0.2%) |
| Sept 2019 | - | -$5.12 M(+45.0%) | -$15.34 M(+10.4%) |
| June 2019 | - | -$3.53 M(+0.5%) | -$13.90 M(-4.6%) |
| Mar 2019 | - | -$3.51 M(+10.7%) | -$14.56 M(+8.9%) |
| Dec 2018 | -$13.37 M(-11.9%) | -$3.17 M(-13.8%) | -$13.37 M(+82.0%) |
| Sept 2018 | - | -$3.68 M(-12.3%) | -$7.34 M(-49.7%) |
| June 2018 | - | -$4.20 M(+81.2%) | -$14.59 M(-0.4%) |
| Mar 2018 | - | -$2.32 M(-181.3%) | -$14.64 M(-3.5%) |
| Dec 2017 | -$15.17 M(-44.3%) | $2.85 M(-126.1%) | -$15.17 M(-25.6%) |
| Sept 2017 | - | -$10.92 M(+156.7%) | -$20.40 M(+14.4%) |
| June 2017 | - | -$4.25 M(+49.5%) | -$17.83 M(-7.4%) |
| Mar 2017 | - | -$2.85 M(+19.8%) | -$19.26 M(-29.3%) |
| Dec 2016 | -$27.25 M(-37.7%) | -$2.38 M(-71.6%) | -$27.25 M(-24.0%) |
| Sept 2016 | - | -$8.35 M(+47.0%) | -$35.86 M(+4.6%) |
| June 2016 | - | -$5.68 M(-47.6%) | -$34.28 M(-18.8%) |
| Mar 2016 | - | -$10.85 M(-1.2%) | -$42.22 M(-3.5%) |
| Dec 2015 | -$43.74 M(+121.1%) | -$10.98 M(+62.1%) | -$43.74 M(+11.5%) |
| Sept 2015 | - | -$6.77 M(-50.3%) | -$39.23 M(+5.0%) |
| June 2015 | - | -$13.62 M(+10.2%) | -$37.37 M(+32.0%) |
| Mar 2015 | - | -$12.36 M(+90.7%) | -$28.30 M(+43.1%) |
| Dec 2014 | -$19.78 M(+60.6%) | -$6.48 M(+32.0%) | -$19.78 M(+12.9%) |
| Sept 2014 | - | -$4.91 M(+7.8%) | -$17.53 M(+9.6%) |
| June 2014 | - | -$4.56 M(+18.7%) | -$15.99 M(+14.8%) |
| Mar 2014 | - | -$3.84 M(-9.1%) | -$13.93 M(+13.1%) |
| Dec 2013 | -$12.32 M(-27.8%) | -$4.22 M(+25.4%) | -$12.32 M(-38.9%) |
| Sept 2013 | - | -$3.37 M(+34.9%) | -$20.16 M(+7.7%) |
| June 2013 | - | -$2.50 M(+12.1%) | -$18.72 M(+3.5%) |
| Mar 2013 | - | -$2.23 M(-81.5%) | -$18.10 M(+6.0%) |
| Dec 2012 | -$17.07 M(+109.4%) | -$12.07 M(+525.2%) | -$17.07 M(+108.5%) |
| Sept 2012 | - | -$1.93 M(+3.1%) | -$8.19 M(+11.3%) |
| June 2012 | - | -$1.87 M(+56.0%) | -$7.36 M(+2.7%) |
| Mar 2012 | - | -$1.20 M(-62.3%) | -$7.16 M(-12.1%) |
| Dec 2011 | -$8.15 M(+376.3%) | -$3.19 M(+190.1%) | -$8.15 M(+39.7%) |
| Sept 2011 | - | -$1.10 M(-34.6%) | -$5.83 M(+6.7%) |
| June 2011 | - | -$1.68 M(-23.1%) | -$5.47 M(+94.7%) |
| Mar 2011 | - | -$2.19 M(+151.1%) | -$2.81 M(+64.2%) |
| Dec 2010 | -$1.71 M | -$870.40 K(+18.8%) | -$1.71 M(-12.5%) |
| Sept 2010 | - | -$732.80 K(-174.8%) | -$1.95 M(+5.8%) |
| June 2010 | - | $979.80 K(-190.1%) | -$1.85 M(-50.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$1.09 M(-2.4%) | -$3.71 M(-0.7%) |
| Dec 2009 | -$3.73 M(-48.2%) | -$1.11 M(+77.9%) | -$3.73 M(+5.6%) |
| Sept 2009 | - | -$626.10 K(-28.8%) | -$3.53 M(-18.5%) |
| June 2009 | - | -$879.60 K(-21.0%) | -$4.34 M(-17.1%) |
| Mar 2009 | - | -$1.11 M(+21.6%) | -$5.23 M(-27.4%) |
| Dec 2008 | -$7.21 M(-27.2%) | -$915.20 K(-35.9%) | -$7.21 M(-23.8%) |
| Sept 2008 | - | -$1.43 M(-19.4%) | -$9.45 M(-6.8%) |
| June 2008 | - | -$1.77 M(-42.7%) | -$10.14 M(+0.1%) |
| Mar 2008 | - | -$3.09 M(-2.2%) | -$10.13 M(+2.4%) |
| Dec 2007 | -$9.89 M(+141.3%) | -$3.16 M(+49.0%) | -$9.89 M(+11.9%) |
| Sept 2007 | - | -$2.12 M(+20.3%) | -$8.84 M(+18.2%) |
| June 2007 | - | -$1.76 M(-38.1%) | -$7.48 M(+16.3%) |
| Mar 2007 | - | -$2.85 M(+35.1%) | -$6.43 M(+56.9%) |
| Dec 2006 | -$4.10 M(+202.3%) | -$2.11 M(+178.5%) | -$4.10 M(+106.1%) |
| Sept 2006 | - | -$757.60 K(+5.8%) | -$1.99 M(+61.5%) |
| June 2006 | - | -$716.20 K(+38.9%) | -$1.23 M(+138.9%) |
| Mar 2006 | - | -$515.50 K(-41.5%) | -$515.50 K(-91.9%) |
| Dec 2005 | -$1.36 M(-84.3%) | - | - |
| Mar 2003 | - | -$880.90 K(-12.3%) | -$6.36 M(-26.1%) |
| Dec 2002 | -$8.62 M(-9.1%) | -$1.00 M(-22.9%) | -$8.62 M(-19.0%) |
| Sept 2002 | - | -$1.30 M(-59.0%) | -$10.64 M(-10.8%) |
| June 2002 | - | -$3.18 M(+1.4%) | -$11.93 M(+8.1%) |
| Mar 2002 | - | -$3.13 M(+3.5%) | -$11.03 M(-40.6%) |
| Dec 2001 | -$9.48 M(+64.5%) | -$3.03 M(+16.7%) | -$18.57 M(+8.3%) |
| Sept 2001 | - | -$2.59 M(+13.7%) | -$17.15 M(+8.0%) |
| June 2001 | - | -$2.28 M(-78.6%) | -$15.87 M(+6.0%) |
| Mar 2001 | - | -$10.67 M(+565.3%) | -$14.98 M(+159.9%) |
| Dec 2000 | -$5.76 M(-66.8%) | -$1.60 M(+21.7%) | -$5.76 M(-67.0%) |
| Sept 2000 | - | -$1.32 M(-4.7%) | -$17.44 M(-1.0%) |
| June 2000 | - | -$1.38 M(-5.0%) | -$17.63 M(-0.7%) |
| Mar 2000 | - | -$1.46 M(-89.0%) | -$17.74 M(+1.7%) |
| Dec 1999 | -$17.38 M(-6.5%) | -$13.28 M(+785.7%) | -$17.45 M(+244.6%) |
| Sept 1999 | - | -$1.50 M(0.0%) | -$5.06 M(-10.6%) |
| June 1999 | - | -$1.50 M(+29.0%) | -$5.66 M(-67.6%) |
| Mar 1999 | - | -$1.16 M(+29.2%) | -$17.46 M(-6.1%) |
| Dec 1998 | -$18.60 M(+95.8%) | -$900.00 K(-57.1%) | -$18.60 M(-3.1%) |
| Sept 1998 | - | -$2.10 M(-84.2%) | -$19.20 M(+1.1%) |
| June 1998 | - | -$13.30 M(+478.3%) | -$19.00 M(+108.8%) |
| Mar 1998 | - | -$2.30 M(+53.3%) | -$9.10 M(-4.2%) |
| Dec 1997 | -$9.50 M(+35.7%) | -$1.50 M(-21.1%) | -$9.50 M(-5.9%) |
| Sept 1997 | - | -$1.90 M(-44.1%) | -$10.10 M(+3.1%) |
| June 1997 | - | -$3.40 M(+25.9%) | -$9.80 M(+21.0%) |
| Mar 1997 | - | -$2.70 M(+28.6%) | -$8.10 M(+14.1%) |
| Dec 1996 | -$7.00 M(-5.4%) | -$2.10 M(+31.3%) | -$7.10 M(+1.4%) |
| Sept 1996 | - | -$1.60 M(-5.9%) | -$7.00 M(-6.7%) |
| June 1996 | - | -$1.70 M(0.0%) | -$7.50 M(-2.6%) |
| Mar 1996 | - | -$1.70 M(-15.0%) | -$7.70 M(+4.1%) |
| Dec 1995 | -$7.40 M(+17.5%) | -$2.00 M(-4.8%) | -$7.40 M(+5.7%) |
| Sept 1995 | - | -$2.10 M(+10.5%) | -$7.00 M(+7.7%) |
| June 1995 | - | -$1.90 M(+35.7%) | -$6.50 M(+4.8%) |
| Mar 1995 | - | -$1.40 M(-12.5%) | -$6.20 M(+19.2%) |
| Dec 1994 | -$6.30 M(+61.5%) | -$1.60 M(0.0%) | -$5.20 M(+2.0%) |
| Sept 1994 | - | -$1.60 M(0.0%) | -$5.10 M(+4.1%) |
| June 1994 | - | -$1.60 M(+300.0%) | -$4.90 M(+28.9%) |
| Mar 1994 | - | -$400.00 K(-73.3%) | -$3.80 M(-2.6%) |
| Dec 1993 | -$3.90 M | -$1.50 M(+7.1%) | -$3.90 M(+62.5%) |
| Sept 1993 | - | -$1.40 M(+180.0%) | -$2.40 M(+140.0%) |
| June 1993 | - | -$500.00 K(0.0%) | -$1.00 M(+100.0%) |
| Mar 1993 | - | -$500.00 K | -$500.00 K |
FAQ
- What is Theriva Biologics annual net profit?
- What is the all time high annual net income for Theriva Biologics?
- What is Theriva Biologics annual net income year-on-year change?
- What is Theriva Biologics quarterly net profit?
- What is the all time high quarterly net income for Theriva Biologics?
- What is Theriva Biologics quarterly net income year-on-year change?
- What is Theriva Biologics TTM net profit?
- What is the all time high TTM net income for Theriva Biologics?
- What is Theriva Biologics TTM net income year-on-year change?
What is Theriva Biologics annual net profit?
The current annual net income of TOVX is -$18.35 M
What is the all time high annual net income for Theriva Biologics?
Theriva Biologics all-time high annual net profit is -$1.36 M
What is Theriva Biologics annual net income year-on-year change?
Over the past year, TOVX annual net profit has changed by +$1.34 M (+6.79%)
What is Theriva Biologics quarterly net profit?
The current quarterly net income of TOVX is -$7.73 M
What is the all time high quarterly net income for Theriva Biologics?
Theriva Biologics all-time high quarterly net profit is $2.85 M
What is Theriva Biologics quarterly net income year-on-year change?
Over the past year, TOVX quarterly net profit has changed by -$4.42 M (-133.91%)
What is Theriva Biologics TTM net profit?
The current TTM net income of TOVX is -$26.69 M
What is the all time high TTM net income for Theriva Biologics?
Theriva Biologics all-time high TTM net profit is -$500.00 K
What is Theriva Biologics TTM net income year-on-year change?
Over the past year, TOVX TTM net profit has changed by -$7.38 M (-38.23%)